Has Michael Reddy-Miller, MD received payments from drug or device companies?

Yes. Drug and device makers reported $677 in general payments to Michael Reddy-Miller, MD across 41 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Reddy-Miller, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Reddy-Miller, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Reddy-Miller, MD

Internal Medicine · Macon, GANPI 1538621172

Payments from drug & device makers

$677in general payments, 2019–2025

Across 41 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$186
Pfizer$100
Melinta Therapeutics, LLC$92
Johnson & Johnson$78
AstraZeneca$71
Aurinia Pharma U.S., Inc.$33
plus $118 from 5 others

What the payments were for

Food & beverage$677100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	12	$186
Pfizer	6	$100
Melinta Therapeutics, LLC	6	$92
Johnson & Johnson	6	$78
AstraZeneca(2 entities)	4	$71
Aurinia Pharma U.S., Inc.	2	$33
Actelion Pharmaceuticals US, Inc.	1	$29
Amgen	1	$28
Novartis	1	$21
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$20
Mylan Specialty L.p.	1	$20

How this compares

$677 in reported general payments places this provider in the 60th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Medicare billing

Part B allowed, 2024

$58,212

Medicare patients

223

Services billed

580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate	11	$418
Atorvastatin Calcium	40	$219
Pantoprazole Sodium	11	$127
Potassium Chloride	19	$122
Metoprolol Succinate	15	$97
Lisinopril	16	$87
Losartan Potassium	20	$85
ClopidogrelClopidogrel Bisulfate	14	$82
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	16	$75
Amlodipine Besylate	24	$61
Famotidine	11	$55
Furosemide	23	$45
Prednisone	21	$38

Paid to pharmacies, not to this prescriber.

Other internal medicine in Macon

Paul BradleySavannah$76.4M
Kimball JohnsonAtlanta$51.1M
Bram WieskopfWoodstock$21.9M
Dwight BlakeUnion City$13.3M
Charlotte Grayson-MathisFayetteville$9.6M
Christopher RecknorGainesville$9.2M
James HarperJohns Creek$9.2M
Robert Springer IiiAtlanta$5.3M
Thomas MoriaritySavannah$4.6M
Charles KempAlbany$2.7M

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →